
After private equity firms bought for-profit hospices, Medicare paid $993 more per hospice encounter and stays ran 6.3 days longer, with no increase in visits.
A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.
In the





